Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy

A compelling spin-off rationale Enhanced focus Greater agility Improved accountability Value creation Generics culture Simplification and optimization of resource allocation Greater freedom to operate and adapt to evolving off-patent medicines market conditions Ambitious targets and clearer business objectives Clear path for profitable growth and enhanced shareholder returns Strengthen entrepreneurial mindset 29 29 Management Presentation SANDOZ

View entire presentation